Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saroj Mathupala

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biotechniques|May 20, 2009
An agarose-based cloning-ring anchoring method for isolation of viable cell clonesSaroj Mathupala, Andrew A Sloan
Neurosurgery|October 29, 2004
Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cellsPrahlad Parajuli, Saroj Mathupala, Andrew E Sloan
Expert Opinion on Biological Therapy|March 22, 2007
Dendritic cell-based active specific immunotherapy for malignant gliomaPrahlad Parajuli, Saroj Mathupala, Sandeep Mittal, et al.
Biochimica Et Biophysica Acta|September 11, 2002
Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic interventionPeter L Pedersen, Saroj Mathupala, Annette Rempel, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biotechniques|May 20, 2009
An agarose-based cloning-ring anchoring method for isolation of viable cell clonesSaroj Mathupala, Andrew A Sloan
Neurosurgery|October 29, 2004
Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cellsPrahlad Parajuli, Saroj Mathupala, Andrew E Sloan
Expert Opinion on Biological Therapy|March 22, 2007
Dendritic cell-based active specific immunotherapy for malignant gliomaPrahlad Parajuli, Saroj Mathupala, Sandeep Mittal, et al.
Biochimica Et Biophysica Acta|September 11, 2002
Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic interventionPeter L Pedersen, Saroj Mathupala, Annette Rempel, et al.
Pageof 1